Hirohito Kubota

17PUBLICATIONS
68CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyHaematological tumoursMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 09, 2025
Statins induce monocytic differentiation in acute myeloid leukemia cells through the KLF4/DPYSL2A axis.

Mina Noura, Kota Shoji, Michidai Nobe

|Mar 21, 2024
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki

|Jan 24, 2024
Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.

Hidemasa Matsuo, Aina Inagami, Yuri Ito

|Dec 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani

|Jul 18, 2022
RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.

Hirohito Kubota, Tatsuya Masuda, Mina Noura

|Jul 06, 2021
Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis.

Mina Noura, Ken Morita, Hiroki Kiyose

Pageof 3

Frequent Collaborators

4 joint publications

Daisuke Tomizawa

3 joint publications

Yasuhiko Kamikubo

3 joint publications

Junko Takita

2 joint publications

Kiminori Terui